SBRT may be effective, safe alternative for patients, medically inoperable early-stage lung cancer

(NRG Oncology) JAMA Oncology recently published data from NRG Oncology's RTOG 0618 trial, which shows that the utilization of Stereotactic Body Radiation Therapy (SBRT) as a treatment for medically operable lung cancer is associated with favorable primary tumor control and local control rates.